European shares concluded Wednesday’s volatile trading session higher, largely due to gains in healthcare firms GSK and Novo Nordisk following their strong quarterly performances. The pan-European STOXX 600 index overcame initial declines to finish up 0.36%, with healthcare leading sectoral advances with a 2.1% increase.
